90 results
Page 2 of 5
8-K
EX-4.2
rv20axdlajc0t
18 Aug 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-4.2
t44yv8y5lhfr 2yv1ou0
23 Apr 21
Adhera Therapeutics Appoints Trond K. Waerness to Board of Directors
9:15am
8-K
EX-4.1
d0jey59d3 xk2kggl
23 Apr 21
Adhera Therapeutics Appoints Trond K. Waerness to Board of Directors
9:15am
8-K
EX-4.1
yyt4223
9 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
EX-4.2
0c848 vqx5c88i7q
9 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
EX-4.2
bu29cel 95v5y83f
5 Nov 20
Entry into a Material Definitive Agreement
3:58pm
8-K
EX-4.1
4xobz 0g8lspv
5 Nov 20
Entry into a Material Definitive Agreement
3:58pm
8-K
EX-4.1
6fe d5pko
30 Jun 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
7blb42wib86fkzkc0
11 Feb 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-4.2
kbtxyr48wca7qtyo
11 Feb 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-4.1
0eqckg6 nokak0wgu
3 Jul 19
Entry into a Material Definitive Agreement
5:00pm
S-8
EX-4.2
juag ybfmcpf7
3 May 19
Registration of securities for employees
5:06pm
8-K
EX-4.1
824v36c2dxi5dla
16 Jul 18
Entry into a Material Definitive Agreement
9:02am
8-K
EX-4.1
zjea4z2tu7vk
19 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
hdgz0ofy
29 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
qlnv1
24 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
f2z i0lg1no
24 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
9reymu
7 Jun 17
Marina Biotech Acquires Prestalia®, a U.S. FDA Approved Drug for Patients Whose Blood Pressure Is Not Adequately Controlled by Monotherapy
12:00am
8-K
EX-4.1
eifo7sgrugd
6 Apr 17
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am